[{"address1": "4 Lui Paster", "city": "Tel Aviv-Jaffa", "zip": "6803605", "country": "Israel", "phone": "972 5 2775 5072", "website": "https://www.raphaelpharmaceutical.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "Raphael Pharmaceutical Inc., a pharmaceutical drug research and development company, focuses on the discovery and clinical development of life-improving drug therapies based on cannabinoids. The company develops product candidate for the treatment of rheumatoid arthritis and hyper inflammatory syndrome inflammation related to COVID-19. It also intends to develop product candidate to treat oncology indications. The company is headquartered in Tel Aviv-Jaffa, Israel.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Shlomo  Pilo", "age": 68, "title": "CEO & Chairman", "yearBorn": 1955, "fiscalYear": 2023, "totalPay": 244000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Guy  Ofir", "age": 50, "title": "General Counsel, CFO & Director", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 144000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Igal Louria Hayon", "age": 50, "title": "Chief Scientist, Chairman of Scientific Advisory Board, CTO & Director", "yearBorn": 1973, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.31, "open": 1.65, "dayLow": 0.75, "dayHigh": 1.65, "regularMarketPreviousClose": 1.31, "regularMarketOpen": 1.65, "regularMarketDayLow": 0.75, "regularMarketDayHigh": 1.65, "volume": 160, "regularMarketVolume": 160, "averageVolume": 12, "bid": 0.2, "ask": 1.65, "marketCap": 30857310, "fiftyTwoWeekLow": 0.6, "fiftyTwoWeekHigh": 1.65, "fiftyDayAverage": 1.65, "twoHundredDayAverage": 1.2353, "currency": "USD", "enterpriseValue": 30737340, "floatShares": 14882401, "sharesOutstanding": 18701400, "heldPercentInsiders": 0.51347, "bookValue": -0.016, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -1401000, "trailingEps": -0.07, "exchange": "OQB", "quoteType": "EQUITY", "symbol": "RAPH", "underlyingSymbol": "RAPH", "shortName": "RAPHAEL PHARMACEUTICAL INC", "longName": "Raphael Pharmaceutical Inc.", "firstTradeDateEpochUtc": 1672929000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "cf548e1c-b736-368b-a155-a3bf786b1252", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.65, "recommendationKey": "none", "totalCash": 120000, "totalCashPerShare": 0.006, "quickRatio": 0.287, "currentRatio": 0.301, "returnOnAssets": -7.03947, "freeCashflow": -570375, "operatingCashflow": -979000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]